Search

Your search keyword '"Moulin, Bruno"' showing total 178 results

Search Constraints

Start Over You searched for: Author "Moulin, Bruno" Remove constraint Author: "Moulin, Bruno" Database Unpaywall Remove constraint Database: Unpaywall
178 results on '"Moulin, Bruno"'

Search Results

1. #1940 Plasma complement activation profile in kidney transplant recipients with IgAN supports the importance of the complement alternative pathway in IgAN

2. #2663 Assessment of in situ alternative and classical convertases as indicators of ongoing glomerular complement activation in IgA nephropathy

3. Primary hyperoxaluria in adults and children: a nationwide cohort highlight a persistent diagnostic delay

5. Tixagevimab-cilgavimab as an Early Treatment for COVID-19 in Kidney Transplant Recipients

7. A rapid decline in the anti–receptor-binding domain of the SARS-CoV-2 spike protein IgG titer in kidney transplant recipients after tixagevimab–cilgavimab administration

8. Breakthrough COVID-19 cases despite prophylaxis with 150 mg of tixagevimab and 150 mg of cilgavimab in kidney transplant recipients

9. Isolated kidney transplantation under lumasiran therapy in primary hyperoxaluria type 1: a report of five cases

10. Tixagevimab-cilgavimab as an early treatment for COVID-19 in kidney transplant recipients

11. A gain-of-function variant in the Wiskott-Aldrich syndrome gene is associated with a MYH9-related disease-like syndrome

12. Pneumococcal and influenza vaccination coverage among at-risk adults: A 5-year French national observational study

13. Prediction of Vaccine Response and Development of a Personalized Anti-SARS-CoV-2 Vaccination Strategy in Kidney Transplant Recipients: Results from a Large Single-Center Study

15. Effectiveness and Tolerance of Renin-Angiotensin System Inhibitors With Aging in Chronic Kidney Disease

18. Urinary collagen-derived peptides as sensitive markers for bone resorption and bisphosphonate treatment in kidney transplant patients

20. The consequences of COVID-19 pandemic on patients with monoclonal gammopathy–associated systemic capillary leak syndrome (Clarkson disease)

22. Factors associated with coinfections in invasive aspergillosis: a retrospective cohort study

23. Strong antibody response after a first dose of a SARS-CoV-2 mRNA-based vaccine in kidney transplant recipients with a previous history of COVID-19

24. Prevalence of Antineutrophil Cytoplasmic Antibody–Associated Vasculitis and Spatial Association With Quarries in a Region of Northeastern France: A Capture–Recapture and Geospatial Analysis

25. SARS-Cov-2 Seroprevalence in a French Kidney Transplant Center Located Within a “High-risk” Zone

26. Clinical Utility of Biochemical Markers for the Prediction of COVID-19−Related Mortality in Kidney Transplant Recipients

27. French nationwide survey of undocumented end-stage renal disease migrant patient access to scheduled haemodialysis and kidney transplantation

29. Corrigendum to Berchtold L, Letouzé E, Alexander MP, et al. HLA-D and PLA2R1 risk alleles associate with recurrent primary membranous nephropathy in kidney transplant recipients. Kidney Int. 2021;99:671–685

30. Bi-allelic variants in IPO8 cause a connective tissue disorder associated with cardiovascular defects, skeletal abnormalities, and immune dysregulation

32. Low immunization rates among kidney transplant recipients who received 2 doses of the mRNA-1273 SARS-CoV-2 vaccine

33. Weak anti–SARS-CoV-2 antibody response after the first injection of an mRNA COVID-19 vaccine in kidney transplant recipients

34. Living kidney donor evaluation for all candidates with normal estimated GFR for age

35. Transition et transfert de la néphrologie pédiatrique à la néphrologie adulte : recommandations de la filière maladies rénales rares ORKiD

37. Weak anti-SARS-CoV-2 antibody response after the first injection of an mRNA COVID-19 vaccine in kidney transplant recipients

38. Is COVID-19 infection more severe in kidney transplant recipients?

39. HLA-D and PLA2R1 risk alleles associate with recurrent primary membranous nephropathy in kidney transplant recipients

41. Liste des collaborateurs

42. Contributors

44. Results of a nation-wide cohort study suggest favorable long-term outcomes of clone-targeted chemotherapy in immunotactoid glomerulopathy

45. Intravenous immunoglobulin as a preventive strategy against BK virus viremia and BKV-associated nephropathy in kidney transplant recipients—Results from a proof-of-concept study

46. Subcutaneous Casirivimab/Imdevimab (Ronapreve™) Injections for Covid-19 Prophylaxis in Kidney Transplant Recipients

47. Development and validation of an optimized integrative model using urinary chemokines for noninvasive diagnosis of acute allograft rejection

48. An initial report from the French SOT COVID Registry suggests high mortality due to COVID-19 in recipients of kidney transplants

49. IMPact of the COVID-19 epidemic on the moRTAlity of kidney transplant recipients and candidates in a French Nationwide registry sTudy (IMPORTANT)

50. In-depth virological assessment of kidney transplant recipients with COVID-19

Catalog

Books, media, physical & digital resources